News | 07 February 2013
Pharmaceutical multinationals are reinforcing their presence in Asia, according to Jones Lang LaSalle's latest Global Life Sciences Cluster Report. Widening patient pools and increasing consumer demand in emerging markets is driving the growth of sales ...
Click on the link to read the full article at Arabian Gazette
(This link will open in a new window)